Welcome back to Endpoints Weekly! The last week of April brought a downpour of news as several pharma companies reported their first-quarter earnings. Max Gelman

Moderna said it’s working with US regulators to provide post-marketing data on its Covid-19 vaccines that could restore their use to a wider group after

The FDA on Friday approved Pfizer and Arvinas’ drug vepdegestrant for patients with a certain form of breast cancer. But it’s unclear how many will

Amgen is launching three new late-stage trials for its long-acting obesity shot MariTide, including one designed to test the drug in patients switching away from

Seaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell. With a team largely made up of Karuna